Swiss National Bank Lannett CO Inc Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$5.75 - $7.13 $423,775 - $525,481	-73,700 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$6.43 - $9.86 $76,517 - $117,334	11,900 Added 19.26%	73,700 $535,000
Q4 2019 Feb 06, 2020	BUY	$8.49 - $12.81 $524,682 - $791,658	61,800 New	61,800 $545,000
Q4 2018 Feb 13, 2019	SELL	$3.43 - $6.19 $191,051 - $344,783	-55,700 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$13.3 - $17.45 $91,770 - $120,405	6,900 Added 14.14%	55,700 $758,000
Q3 2017 Nov 03, 2017	BUY	$15.1 - $19.25 $736,880 - $939,400	48,800	48,800 $900,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.